Case Author(s): John R. Leahy, M.D. and Barry A. Siegel, M.D. , 9/11/98 . Rating: #D3, #Q3

Diagnosis: Metastatic cervical carcinoma

Brief history:

38 year old woman with profuse vaginal bleeding.

Images:

Contiguous coronal images

View main image(pt) in a separate image viewer

View second image(ct). CT of the pelvis obtained several days prior to PET study

Full history/Diagnosis is available below


Diagnosis: Metastatic cervical carcinoma

Full history:

38 year old woman presented with vaginal bleeding. Cervical carcinoma was diagnosed by biopsy. Subsequent CT scan revealed a large pelvic mass and the patient was referred to Radiation Oncology for further management.

Radiopharmaceutical:

15.0 mCi F-18 fluorodeoxyglucose i.v.

Findings:

Several foci of increased F-18 fluorodeoxyglucose (FDG) accumulation are seen. This includes a large, heterogeneous pelvic mass, which correlates to the cervical mass noted on CT, and is consistent with the patient's primary tumor. There are also several foci of intense FDG accumulation along the courses of both iliac nodal chains with extension along the course of the periaortic nodal chains. An additional focus of intense activity is seen in the left supraclavicular region, likely representing a lymph node metastasis. The results of PET are therefore consistent with stage IV cervical cancer. The degree of lymphadenopathy demonstrated on this PET study is more extensive than that seen on CT. No hydronephrosis is appreciated.

Discussion:

Cervical carcinoma metastasizes from the primary site in a predictable pattern. Disease extends through pelvic lymph nodes, iliac chains, and along the aorta, before finally to spreading to extranodal sites such as lung or liver. The presence of lymph node metastases does not alter the FIGO clinical stage, but indicates a worse prognosois and can influence the choice of therapy. Detection of lymph node involvement by CT is limited by size criteria, having a sensitivity of 34% and specificity of 96%. PET depends on metabolic rather than size criteria for detection of nodal involvement. Preliminary data show that PET can detect metastatic disease, both locoregional and distant, with greater sensitivity than conventional imaging studies, as is evidenced in this study. PET also shows utility in assessment of recurrent disease.

References:

Grigsby PW, Dehdashti F, Siegel BA. FDG-PET evaluation of carcinoma of the cervix. Clin Positron Imaging 1999; 2:105-9.

Rose PG, Adler LP, Rodriguez M, Faulhaber PF, Abdul-Karim FW, Miraldi F. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J Clin Oncol 1999; 17:41-5.

Sugawara Y, Eisbruch A, Kosuda S, Recker BE, Kison PV, Wahl RL. Evaluation of FDG PET in patients with cervical cancer. J Nucl Med 1999; 40:1125-31.

Followup:

The woman received implant radiation and chemotherapy for the primary tumor. She also underwent external beam radiation to the abdominopelvic and supraclavicular lymph node metastases detected by PET. She returned on 8/11/98 for interval evaluation of her disease.

Findings:

The first set of images--coronal images obtained on 8/11/98--shows resolution of activity in the primary tumor and the original lymph node metastases (because of a malfunctioning Foley catheter, there is a large amount of urine in the bladder). There are three new foci of abnormal FDG accumulation in the mid abdominal periaortic lymph nodes, as well as two new foci in the posterior mediastinum and left pulmonary hilum.

The second and third sets--comparison coronal and sagittal images--more clearly show the interval changes from April to August. There is decreased marrow activity extending from the sacrum to the L1 level. This suggests fatty marrow replacement, and corresponds to the radiation port used to treat the original lymph node metastases. Note that metastatic disease has now developed in the nodal chain just above the radiation port.

Given the rapid development of the new foci, they likely arose from micrometastases present, but not detectected on the first PET study. These foci were not covered in the radiation port.

View followup image(pt). Three sets of images: 1. Coronal images from 8/11/98. 2. Comparison of coronal images from 4/98 and 8/98. 3. Comparison of sagittal images from 4/98 and 8/98

ACR Codes and Keywords:

References and General Discussion of PET Tumor Imaging Studies (Anatomic field:Genitourinary System, Category:Neoplasm, Neoplastic-like condition)

Search for similar cases.

Edit this case

Add comments about this case

Read comments about this case

Return to the Teaching File home page.


Case number: pt020

Copyright by Wash U MO